| Entry |
|
|---|
| Name |
Fosfomycin tromethamine (USP);
Monurol (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C3H7O4P. C4H11NO3
|
|---|
| Exact mass |
259.0821
|
|---|
| Mol weight |
259.19
|
|---|
| Structure |
|
|---|
| Remark |
| Product (DG00633): | D00925<US> D02187<JP> D02188<JP> |
|
|---|
| Efficacy |
Antibacterial, Cell wall biosynthesis inhibitor |
|---|
| Target |
UDP-N-acetylglucosamine 1-carboxyvinyltransferase [KO: K00790] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XX Other antibacterials
J01XX01 Fosfomycin
D00925 Fosfomycin tromethamine (USP) <US>
S SENSORY ORGANS
S02 OTOLOGICALS
S02A ANTIINFECTIVES
S02AA Antiinfectives
S02AA17 Fosfomycin
D00925 Fosfomycin tromethamine (USP) <US>
USP drug classification [BR:br08302]
Antibacterials
Antibacterials, Other
Fosfomycin
D00925 Fosfomycin tromethamine (USP)
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
D00925 Fosfomycin tromethamine (USP) <US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
DG00633 Fosfomycin
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 16
1 C1y C 24.4300 -17.6400
2 C1y C 25.7600 -17.6400
3 O2x O 25.0600 -16.4500
4 P1b P 23.2400 -18.4100
5 C1a C 26.9500 -18.4100
6 O1c O 21.9800 -19.1100
7 O1c O 22.5400 -17.1500
8 O1c O 23.9400 -19.6000
9 C1d C 32.6782 -18.3810
10 C1b C 31.5325 -17.7204
11 C1b C 32.6782 -19.7313
12 C1b C 33.8240 -17.7379
13 N1a N 32.7193 -16.5512
14 O1a O 30.3867 -18.3810
15 O1a O 33.8240 -20.3919
16 O1a O 34.9873 -18.3985
BOND 15
1 1 2 1
2 2 3 1
3 3 1 1
4 1 4 1 #Up
5 2 5 1 #Up
6 4 6 2
7 4 7 1
8 4 8 1
9 9 10 1
10 9 11 1
11 9 12 1
12 9 13 1
13 10 14 1
14 11 15 1
15 12 16 1
|
|---|
